Mercer Global Advisors Inc Tenaya Therapeutics, Inc. Transaction History
Mercer Global Advisors Inc
- $48.3 Billion
- Q2 2025
A detailed history of Mercer Global Advisors Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 16,661 shares of TNYA stock, worth $23,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,661Holding current value
$23,325% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
92Shares Held
36.8MCall Options Held
91.4KPut Options Held
50.3K-
Column Group LLC San Francisco, CA9.4MShares$13.2 Million8.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.76MShares$6.66 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$5.7 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$3.16 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.84MShares$2.58 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $57.9M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...